Dr. Timothy T. Goodnow serves as the President and Chief Executive Officer of Senseonics Holdings Inc. Having guided the enterprise through key regulatory approvals, international distribution partnerships, and the strategic transition to direct commercial operations in the United States, he oversees long-term product innovation, clinical trial expansion, and corporate growth initiatives within the competitive diabetes management sector.